While an investigation has just been opened after the death of a nonagenarian on diuretics, the laboratory responsible for the poor packaging of this drug should be inspected on Monday by the ANSM.
According to information revealed by Le Figaro, from tomorrow Monday two or three pharmacists specializing in good manufacturing practices from the National Medicines Safety Agency (ANSM), will go to the Teva generic laboratory factory in Sens in Yonne to carry out an inspection .
This ANSM inspection comes at a time when an investigation has just been opened following the death of a nonagenarian in Marseille. This man died on Saturday evening after taking a diuretic for several days which could have been obtained from a poorly conditioned batch. Several boxes of Teva’s diuretic were found at her home and among them, one belonged to the famous poorly packaged batch.
Since Friday, June 8, two batches of furosemide, a diuretic from the Teva laboratory, had to be recalled by the National Medicines Safety Agency (ANSM). Indeed, following a packaging problem, “some tablets have been replaced by tablets of the sleeping pill Zopiclone also called Imovane”, indicated the ANSM in a statement.
Boxes from lots Y175 (expiration date: 08/2015) and Y176 (expiry date: 08/2015), – each lot contains 95,000 boxes -, have therefore been withdrawn from sale since Friday evening and people who already have boxes bearing these numbers must return them to their pharmacist who will provide them with a new one. . The Teva laboratory indicated that the alert had been “given by a pharmacist whose patient had observed unusual drowsiness effects”.
A toll-free number has been made available to people taking this diuretic. This is 0800 51 34 11.
.